Vice President for Research at UT Health Science Center at San Antonio
Vice president, chief strategy and operating officer of the Texas Medical Center
Managing Director, D.E. Shaw and Co., L.P.
Medical College of Wisconsin director of research commercialization
Founding Director, Massachusetts Technology Transfer Center
President and CEO of the Central Indiana Corporate Partnership
Professor of Systems Biology, Columbia University
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
The federal Small Business Innovation Research (SBIR) program is a critical source of (non-dilutive!) funding for early stage companies, providing over $2 billion annually. New changes will increase the funding levels dedicated to the program and expand eligibility to small businesses that are majority-owned by multiple venture capital funds, hedge funds, or private equity firms. Hear from the Director of the National Cancer Institute’s (NCI) SBIR Development Center about new opportunities and about other initiatives, including the NCI SBIR Bridge Award ($3M awards in which NCI co-invests with private investors), and the NCI Investor Forum (connecting innovative SBIR awardees with top-tier investors and partners). More information and online registration is here.